Diversity of chlamydia trachomatis in trachoma-hyperendemic communities treated with azithromycin

Stephanie A. Chin, Daniel P. Morberg, Wondu Alemayehu, Muluken Melese, Takele Lakew, Michael Chen, Zhaoxia Zhou, Thuy Doan, Vicky Cevallos, Thomas M. Lietman, Jeremy D. Keenan

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Prior studies have theorized that low chlamydial genetic diversity following mass azithromycin treatments for trachoma may create a population bottleneck that prevents the return of infection, but little empirical evidence exists to support this hypothesis. In this study, a singlemass azithromycin distribution was administered to 21 communities in theGurage Zone of Ethiopia in 2003. All children aged 1-5 years had conjunctival swabs performed before treatment and 2 and 6 months after treatment. All swabs positive for Chlamydia trachomatis at 2 months underwent typing of the gene encoding the major outer membrane protein (ompA) of C. trachomatis, as did the same number of swabs per community from the pretreatment and 6-month visits. Diversity of ompA types, expressed as the reciprocal of Simpson's index,was calculated for each community. In total, 15 ompA types belonging to the A and B genovars were identified. The mean diversity was 2.11 (95% confidence interval: 1.79, 2.43) before treatment and 2.16 (95% confidence interval: 1.76, 2.55) 2months after treatment (P = 0.78, paired t test). Diversity of ompA was not associated with the prevalence of ocular chlamydia (P = 0.76) and did not predict subsequent changes in the prevalence of ocular chlamydia (P = 0.32). This study found no evidence to support the theory that ompA diversity is associated with transmission of ocular chlamydia.

Original languageEnglish (US)
Pages (from-to)1840-1845
Number of pages6
JournalAmerican journal of epidemiology
Volume187
Issue number9
DOIs
StatePublished - Jan 1 2018

Fingerprint

Trachoma
Azithromycin
Chlamydia trachomatis
Chlamydia
Confidence Intervals
Therapeutics
Ethiopia
Infection
Population
Genes

All Science Journal Classification (ASJC) codes

  • Epidemiology

Cite this

Chin, S. A., Morberg, D. P., Alemayehu, W., Melese, M., Lakew, T., Chen, M., ... Keenan, J. D. (2018). Diversity of chlamydia trachomatis in trachoma-hyperendemic communities treated with azithromycin. American journal of epidemiology, 187(9), 1840-1845. https://doi.org/10.1093/aje/kwy071
Chin, Stephanie A. ; Morberg, Daniel P. ; Alemayehu, Wondu ; Melese, Muluken ; Lakew, Takele ; Chen, Michael ; Zhou, Zhaoxia ; Doan, Thuy ; Cevallos, Vicky ; Lietman, Thomas M. ; Keenan, Jeremy D. / Diversity of chlamydia trachomatis in trachoma-hyperendemic communities treated with azithromycin. In: American journal of epidemiology. 2018 ; Vol. 187, No. 9. pp. 1840-1845.
@article{3f3cf118ea574569b094d397187dbe85,
title = "Diversity of chlamydia trachomatis in trachoma-hyperendemic communities treated with azithromycin",
abstract = "Prior studies have theorized that low chlamydial genetic diversity following mass azithromycin treatments for trachoma may create a population bottleneck that prevents the return of infection, but little empirical evidence exists to support this hypothesis. In this study, a singlemass azithromycin distribution was administered to 21 communities in theGurage Zone of Ethiopia in 2003. All children aged 1-5 years had conjunctival swabs performed before treatment and 2 and 6 months after treatment. All swabs positive for Chlamydia trachomatis at 2 months underwent typing of the gene encoding the major outer membrane protein (ompA) of C. trachomatis, as did the same number of swabs per community from the pretreatment and 6-month visits. Diversity of ompA types, expressed as the reciprocal of Simpson's index,was calculated for each community. In total, 15 ompA types belonging to the A and B genovars were identified. The mean diversity was 2.11 (95{\%} confidence interval: 1.79, 2.43) before treatment and 2.16 (95{\%} confidence interval: 1.76, 2.55) 2months after treatment (P = 0.78, paired t test). Diversity of ompA was not associated with the prevalence of ocular chlamydia (P = 0.76) and did not predict subsequent changes in the prevalence of ocular chlamydia (P = 0.32). This study found no evidence to support the theory that ompA diversity is associated with transmission of ocular chlamydia.",
author = "Chin, {Stephanie A.} and Morberg, {Daniel P.} and Wondu Alemayehu and Muluken Melese and Takele Lakew and Michael Chen and Zhaoxia Zhou and Thuy Doan and Vicky Cevallos and Lietman, {Thomas M.} and Keenan, {Jeremy D.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1093/aje/kwy071",
language = "English (US)",
volume = "187",
pages = "1840--1845",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "9",

}

Chin, SA, Morberg, DP, Alemayehu, W, Melese, M, Lakew, T, Chen, M, Zhou, Z, Doan, T, Cevallos, V, Lietman, TM & Keenan, JD 2018, 'Diversity of chlamydia trachomatis in trachoma-hyperendemic communities treated with azithromycin', American journal of epidemiology, vol. 187, no. 9, pp. 1840-1845. https://doi.org/10.1093/aje/kwy071

Diversity of chlamydia trachomatis in trachoma-hyperendemic communities treated with azithromycin. / Chin, Stephanie A.; Morberg, Daniel P.; Alemayehu, Wondu; Melese, Muluken; Lakew, Takele; Chen, Michael; Zhou, Zhaoxia; Doan, Thuy; Cevallos, Vicky; Lietman, Thomas M.; Keenan, Jeremy D.

In: American journal of epidemiology, Vol. 187, No. 9, 01.01.2018, p. 1840-1845.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Diversity of chlamydia trachomatis in trachoma-hyperendemic communities treated with azithromycin

AU - Chin, Stephanie A.

AU - Morberg, Daniel P.

AU - Alemayehu, Wondu

AU - Melese, Muluken

AU - Lakew, Takele

AU - Chen, Michael

AU - Zhou, Zhaoxia

AU - Doan, Thuy

AU - Cevallos, Vicky

AU - Lietman, Thomas M.

AU - Keenan, Jeremy D.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Prior studies have theorized that low chlamydial genetic diversity following mass azithromycin treatments for trachoma may create a population bottleneck that prevents the return of infection, but little empirical evidence exists to support this hypothesis. In this study, a singlemass azithromycin distribution was administered to 21 communities in theGurage Zone of Ethiopia in 2003. All children aged 1-5 years had conjunctival swabs performed before treatment and 2 and 6 months after treatment. All swabs positive for Chlamydia trachomatis at 2 months underwent typing of the gene encoding the major outer membrane protein (ompA) of C. trachomatis, as did the same number of swabs per community from the pretreatment and 6-month visits. Diversity of ompA types, expressed as the reciprocal of Simpson's index,was calculated for each community. In total, 15 ompA types belonging to the A and B genovars were identified. The mean diversity was 2.11 (95% confidence interval: 1.79, 2.43) before treatment and 2.16 (95% confidence interval: 1.76, 2.55) 2months after treatment (P = 0.78, paired t test). Diversity of ompA was not associated with the prevalence of ocular chlamydia (P = 0.76) and did not predict subsequent changes in the prevalence of ocular chlamydia (P = 0.32). This study found no evidence to support the theory that ompA diversity is associated with transmission of ocular chlamydia.

AB - Prior studies have theorized that low chlamydial genetic diversity following mass azithromycin treatments for trachoma may create a population bottleneck that prevents the return of infection, but little empirical evidence exists to support this hypothesis. In this study, a singlemass azithromycin distribution was administered to 21 communities in theGurage Zone of Ethiopia in 2003. All children aged 1-5 years had conjunctival swabs performed before treatment and 2 and 6 months after treatment. All swabs positive for Chlamydia trachomatis at 2 months underwent typing of the gene encoding the major outer membrane protein (ompA) of C. trachomatis, as did the same number of swabs per community from the pretreatment and 6-month visits. Diversity of ompA types, expressed as the reciprocal of Simpson's index,was calculated for each community. In total, 15 ompA types belonging to the A and B genovars were identified. The mean diversity was 2.11 (95% confidence interval: 1.79, 2.43) before treatment and 2.16 (95% confidence interval: 1.76, 2.55) 2months after treatment (P = 0.78, paired t test). Diversity of ompA was not associated with the prevalence of ocular chlamydia (P = 0.76) and did not predict subsequent changes in the prevalence of ocular chlamydia (P = 0.32). This study found no evidence to support the theory that ompA diversity is associated with transmission of ocular chlamydia.

UR - http://www.scopus.com/inward/record.url?scp=85053230455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053230455&partnerID=8YFLogxK

U2 - 10.1093/aje/kwy071

DO - 10.1093/aje/kwy071

M3 - Article

C2 - 29617922

AN - SCOPUS:85053230455

VL - 187

SP - 1840

EP - 1845

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 9

ER -